Bausch Health to repay $275 million more in secured term loans

By Rebecca Melvin

New York, Dec. 30 – Bausch Health Cos. Inc. announced it will pay down an additional $275 million of its senior secured term loans using cash on hand and cash generated from operations. Following the repayment, the company will have no debt maturities or mandatory amortization payments until 2024, according to a company news release on Tuesday.

The company’s total debt repayment in the fourth quarter will be about $480 million; and for the full year of 2020, the company will repay a total of about $900 million of debt from cash on hand and cash generated from operations, the release said.

The Laval, Quebec-based company makes pharmaceuticals, medical devices and over-the-counter products, primarily for eye health, gastroenterology and dermatology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.